Crossmark

Targeting cPLA2α inhibits gastric cancer and augments chemotherapy efficacy via suppressing Ras/MEK/ERK and Akt/β-catenin pathways

Published Online: 2021-07-13

Published Print: 2021-10

Authors

Liao, Yingying

Chen, Wei

Shi, Wei https://orcid.org/0000-0002-0834-8592
Zha, Huolong
Funding

Funding for this research was provided by:

the Nature Science Foundation of Hubei Province (2017CFB606)
License Information

Text and Data Mining valid from 2021-07-13

Version of Record valid from 2021-07-13
More Information

Article History

Received: 10 April 2021

Accepted: 5 July 2021

First Online: 13 July 2021

Declarations

:

: The authors declare that they have no competing interests.

: This study was approved by the ethics committee of Renmin Hospital, Hubei University of Medicine.

: Not applicable.

Document is current